A new agreement has been signed between the Fijian and Chinese governments that will see the construction of a health an...
Shuwen Biotech is the first in China to launch a locally manufactured proprietary PD-L1 test kit, which can accurately d...
Chow Tai Fook is collaborating with BookDoc, the largest integrated healthcare app in Southeast Asia ...
EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, has ...
This year at the Eastern Economic Forum in Vladivostok, BIOCAD and Shanghai Pharmaceuticals Holding entered into a Memor...
A recent circular issued by the Chinese State Drug Administration (SDA), has opened up a large market for Contract Resea...
WuXi Biologics (2269.HK, WuXi Bio), a leading global open-access biologics technology platform company offering end-to-e...
XW Laboratories Inc. (XW Labs), a clinical-stage biopharmaceutical company focused on developing innovative small molecu...
China has developed its own heart stent and has published its clinical trial results online in the world-leading medical...
Biocartis Group NV, an innovative molecular diagnostics company, and Guangzhou Wondfo Biotech Co., Ltd., a fast growing ...
WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate...
Chinese online B2C pharmacy and healthcare services platform Jianke has announced that it has successfully closed a...
Singapore - Eisai and collaboration partner Merck announce that the China National Medical Products Administration ...
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...
Chinese researchers say they have developed an artificial intelligence (AI) model with medical imaging to accurately det...
Boehringer Ingelheim (BI) and Tsinghua University in Beijing have announced a collaboration aiming to research and devel...
Asia Pacific is predicted to be the fastest growing market for synthetic biology from 2018 to 2025, driving increased de...
Bio-Thera Solutions, a global biopharmaceutical company recently announced that the China National Drug Administration (...
